Boston Children's Hospital

A study shows liraglutide, combined with diet and exercise, is safe and effective for kids aged 6-11, reducing BMI and improving health markers. Novo Nordisk seeks US approval for this age group, aiming to treat common childhood obesity. Side effects, mainly gastrointestinal, were common but mostly mild. Experts emphasize careful consideration of risks and long-term effects.

A fentanyl vaccine developed by University of Houston researchers is expected to enter clinical trials mid-next year, aiming to prevent the opioid from entering the brain and causing overdose. The vaccine, successful in animal studies, is licensed to Ovax, which raised over $10 million for its production and testing. Despite challenges, including lengthy clinical trial processes and stigma around addiction, the vaccine is seen as a potential tool in the fight against the opioid crisis.